Unlocking the potential of organoids in modern drug discovery
Explore how organoids are unlocking new possibilities in modern drug discovery by improving disease modelling within DMTA-driven research workflows.
Read the full articleYou might also wanna read
Scientists' Side Hustle? Using AI and Quantum Computing to Generate New Peptides
Researchers cobbled together funding and time to show how quantum computing could aid in the development of drugs to help underserved popula
Quantum Computing's Bold Step Into Drug Development
Quantum computing isn't just a science experiment anymore. it's edging into the world of pharmaceuticals. But can it really deliver on its p
Scaling Organ-on-a-Chip Technology for Human-Relevant Drug Discovery
Learn how Organ-on-a-Chip technology supports human-relevant preclinical research and how Liver-Chip models can improve prediction of drug-i
TandemAI and Mila Partner to Apply World Models to AI-Driven Drug Discovery
TandemAI and Mila are collaborating to accelerate drug discovery using machine learning, focusing on “world models” to understand chemical s
quantumzeitgeist.com·1mo agoMCP and Pharma: How AI Agents Connect to Drug Discovery, Clinical Trials, Genomics, Chemical Databases, Protein Structure, FDA Regulatory Data, and Life Sciences Platforms
A comprehensive guide to MCP integrations for pharmaceuticals, biotechnology, and life sciences — covering drug discovery tools (RDKit, mole
Chronic Pancreatitis Therapies Informed by Patient-Derived Organoids
Organoids have become a prevalent tool to bridge the gap between cell and human studies. A new organoid study uncovers chronic pancreatitis
Comments
Sign in to join the conversation.
No comments yet. Be the first.